前臨床画像市場 : 2029年までの世界予測

Preclinical Imaging Market - Global Forecast To 2029

前臨床画像市場 : 製品タイプ（光学イメージング、PET、SPECT、光学イメージング試薬、造影剤、核イメージング試薬）、用途（腫瘍学、神経学）、エンドユーザー（製薬、イメージングセンター）、市場規模シェアおよび動向 - 2029年までの世界予測

Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Global Forecast to 2029

出版年月	2024年5月
ページ数	591
図表数	1,045
価格タイプ	シングルユーザライセンス
価格	USD 4,950
種別	英文調査報告書

The preclinical imaging market is projected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR 5.9% during the forecast period.

前臨床画像市場は、予測期間中のCAGR 5.9%で、2024年の9億4,600万米ドルから2029年までに12億5,900万米ドルに達すると予測されています。

The market growth is mainly driven by factors such as increasing market demand for new drug development and noninvasive small-animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches, technological advancements in the field of molecular imaging, and development of low-cost & affordable preclinical imaging systems.

“Optical Imaging System accounted for the largest share of the market in the forecast period, by product type.”

Based on product, the preclinical imaging market is segmented into imaging systems, reagents, and software. The imaging systems is further segmented into optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic imaging, and magnetic particle imaging. The optical imaging segment captured the largest market share, primarily due to its extensive application in small animal imaging and new drug discovery projects. Several factors have contributed to the growing adoption of optical preclinical imaging. Technological advancements in molecular imaging have significantly enhanced the field, offering researchers more sophisticated and precise imaging capabilities.

“Oncology segment accounted for the largest share of the market in the forecast period, by application.”

Based on application, the preclinical imaging market is segmented into oncology, cardiology, neurology, infectious diseases, immunology and inflammation, and other applications. Among the preclinical imaging applications, oncology holds the largest share. This can be due to several factors such as preclinical imaging enables researchers to track tumor progression and treatment response in the same animal over time. This is particularly valuable in oncology for assessing the effectiveness of new drugs and therapies.

“The pharmaceutical and biotechnology companies segment accounted for the largest share of the market in the forecast period, by end user.”

Based on end user, the preclinical imaging market is segmented into pharmaceutical & biotechnology companies, academic and research centers, imaging centers, and other end users. The pharmaceutical & biotechnology companies segment accounted for the largest share during the forecast period. The demand for preclinical imaging in biotech companies has been steadily rising in recent years and is projected to continue growing. This increasing market demand in pharmaceutical and biotech companies is driven by the spread of emerging and re-emerging infectious diseases. Preclinical imaging is essential for gaining a better understanding of pathogens and for aiding the development of new therapeutics and vaccines.

“Asia Pacific to register the highest growth in the preclinical imaging market in the forecast period.”

The global preclinical imaging market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and Middle East & Africa. In 2023, Asia Pacific was expected to register the highest growth for preclinical imaging market in the forecast period. Factors such as lower research costs, less stringent regulatory guidelines, and increased government funding for the development of the research and development sector in these countries are making the region attractive for preclinical research studies. Consequently, the clinical research outsourcing (CRO) industry is thriving in emerging countries like China and India.

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:

• By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)

• By Designation: C-level Executives (27%), Director-level (18%), and Others (55%)

• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and Middle East and Africa (5%)

The prominent players in this market are Bruker Corporation (US), Revvity, Inc. (US), MR Solutions (UK), Mediso Ltd. (UK), Trefoil Imaging (US), Fujifilm Visual Sonics (Canada), MILABS B.V. (Netherlands), Aspect Imaging Limited (US), Li-Cor Biosciences (US), ICONEUS (Paris), Advanced Molecular Vision (UK), IVIM Technology Corp. (South Korea), Cubresa, Inc. (Canada), Berthold Technologies GMBH & CO.KG (Germany), Sofie (US), Viewworks (Korea), AI4R (France), Kub Technologies (US), Medikor (US), and Miltenyi Biotech GmbH (Germany) . Players adopted organic as well as inorganic growth strategies such as new product launches, acquisitions, and expansions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

The report studies the preclinical imaging market based on product type, application, end user, and region. The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total brain computer interface market. The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

 Analysis of key drivers (technological advancements in the field of molecular imaging, increasing market demand for noninvasive small-animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches, and development of low-cost & affordable preclinical imaging systems), restraints (strict regulation, significant installation and operational cost ), opportunities (expansion in emerging markets, and increasing demand for non-invasive techniques) and challenge (Technological and procedural limitations associated with standalone preclinical imaging systems)

 Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the preclinical imaging market.

 Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of preclinical imaging solutions across regions.

 Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the preclinical imaging market.

 Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the preclinical imaging market.

1 INTRODUCTION 91

1.1 STUDY OBJECTIVES 91

1.2 MARKET DEFINITION 91

1.3 INCLUSIONS & EXCLUSIONS OF STUDY 92

1.4 MARKET SCOPE 93

1.4.1 MARKET SEGMENTATION 93

FIGURE 1 PRECLINICAL IMAGING MARKET SEGMENTATION 93

1.4.2 REGIONAL SCOPE 94

1.5 YEARS CONSIDERED 94

1.6 CURRENCY CONSIDERED 95

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 95

1.7 LIMITATIONS 95

1.8 STAKEHOLDERS 96

1.9 SUMMARY OF CHANGES 96

1.9.1 RECESSION IMPACT 97

2 RESEARCH METHODOLOGY 98

2.1 RESEARCH DATA 98

FIGURE 2 RESEARCH DESIGN 98

2.1.1 SECONDARY DATA 98

2.1.1.1 Key data from secondary sources 99

2.1.2 PRIMARY DATA 100

2.1.2.1 Primary sources 100

2.1.2.2 Key data from primary sources 101

2.1.2.3 Key industry insights 101

2.1.2.4 Breakdown of primary interviews 102

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 102

FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 102

2.2 MARKET SIZE ESTIMATION 102

FIGURE 5 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS 103

FIGURE 6 PRECLINICAL IMAGING MARKET: COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION 104

FIGURE 7 PRECLINICAL IMAGING MARKET: BOTTOM-UP APPROACH 105

FIGURE 8 PRECLINICAL IMAGING MARKET: TOP-DOWN APPROACH 106

2.3 GROWTH FORECAST 106

FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PRECLINICAL IMAGING MARKET (2024–2029) 107

FIGURE 10 PRECLINICAL IMAGING MARKET: CAGR PROJECTIONS 108

2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 108

FIGURE 11 DATA TRIANGULATION METHODOLOGY 109

2.5 RESEARCH ASSUMPTIONS 109

2.6 MARKET FORECAST 110

TABLE 2 FACTOR ANALYSIS 110

2.7 RISK ANALYSIS 110

2.8 RECESSION IMPACT ANALYSIS 110

TABLE 3 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH) 111

TABLE 4 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 112

TABLE 5 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 112

3 EXECUTIVE SUMMARY 113

FIGURE 12 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 113

FIGURE 13 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 114

FIGURE 14 PRECLINICAL IMAGING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 114

FIGURE 15 GEOGRAPHIC SNAPSHOT OF PRECLINICAL IMAGING MARKET 115

4 PREMIUM INSIGHTS 116

4.1 PRECLINICAL IMAGING MARKET OVERVIEW 116

FIGURE 16 TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR IMAGING TO DRIVE MARKET 116

4.2 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT AND COUNTRY (2023) 117

FIGURE 17 IMAGING SYSTEMS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PRECLINICAL IMAGING MARKET IN 2023 117

4.3 PRECLINICAL IMAGING SYSTEMS MARKET: REGIONAL MIX 117

FIGURE 18 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 117

4.4 PRECLINICAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 118

FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 118

4.5 PRECLINICAL IMAGING MARKET: DEVELOPED VS. EMERGING ECONOMIES 118

FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 118

5 MARKET OVERVIEW 119

5.1 INTRODUCTION 119

5.2 MARKET DYNAMICS 119

FIGURE 21 PRECLINICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 119

5.2.1 DRIVERS 120

5.2.1.1 Technological advancements in molecular imaging 120

5.2.1.2 Increasing demand for noninvasive small-animal imaging techniques 120

5.2.1.3 Growing number of public-private initiatives and funding to support preclinical imaging 121

5.2.2 RESTRAINTS 122

5.2.2.1 Stringent regulations governing preclinical research 122

5.2.2.2 Significant installation and operational costs associated with preclinical imaging modalities 123

5.2.3 OPPORTUNITIES 123

5.2.3.1 Emerging markets to offer growth opportunities 123

5.2.4 CHALLENGES 124

5.2.4.1 Technological and procedural limitations associated with standalone preclinical imaging systems 124

5.3 INDUSTRY TRENDS 124

5.3.1 IMAGING BIOMARKERS 124

5.3.2 MULTIMODAL IMAGING 125

5.4 TECHNOLOGY ANALYSIS 125

5.4.1 KEY TECHNOLOGIES 125

5.4.1.1 Photoacoustic tomography – MRI technology 125

5.4.1.2 Multispectral optoacoustic tomography 126

5.4.2 ADJACENT TECHNOLOGIES 126

5.4.2.1 Contrast agents 126

5.4.2.2 Magnetic particle imaging 126

5.4.3 COMPLEMENTARY TECHNOLOGIES 127

5.4.3.1 Molecular imaging 127

5.4.4 PRICING ANALYSIS 127

5.4.4.1 Average selling price trend, by region 128

TABLE 6 AVERAGE SELLING PRICE TREND OF PRECLINICAL IMAGING SYSTEMS, BY REGION 128

5.4.4.2 Average selling price trend of key players, by product 128

TABLE 7 AVERAGE SELLING PRICE OF PRECLINICAL IMAGING PRODUCTS 128

5.5 VALUE CHAIN ANALYSIS 128

FIGURE 22 PRECLINICAL IMAGING MARKET: VALUE CHAIN ANALYSIS: 129

5.6 ECOSYSTEM ANALYSIS 129

FIGURE 23 PRECLINICAL IMAGING MARKET: ECOSYSTEM ANALYSIS 130

5.7 PORTER’S FIVE FORCES ANALYSIS 130

TABLE 8 PRECLINICAL IMAGING MARKET: PORTER’S FIVE FORCES 130

FIGURE 24 PRECLINICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 131

5.7.1 BARGAINING POWER OF BUYERS 131

5.7.2 BARGAINING POWER OF SUPPLIERS 131

5.7.3 THREAT OF NEW ENTRANTS 132

5.7.4 THREAT OF SUBSTITUTES 132

5.7.5 INTENSITY OF COMPETITIVE RIVALRY 132

5.8 REGULATORY LANDSCAPE 132

5.8.1 NORTH AMERICA 132

5.8.1.1 US 132

TABLE 9 US FDA: CLASSIFICATION OF MEDICAL DEVICES 133

5.8.1.2 Canada 133

TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 133

5.8.2 EUROPE 134

5.8.3 ASIA PACIFIC 134

5.8.3.1 Japan 134

TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 134

5.8.3.2 China 135

TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 135

5.8.3.3 India 136

5.8.4 LATIN AMERICA 137

5.8.4.1 Brazil 137

5.8.5 MIDDLE EAST & AFRICA 137

5.8.5.1 UAE 137

5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 137

TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 137

TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 137

TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 138

5.9 PATENT ANALYSIS 138

5.9.1 PATENT PUBLICATION TRENDS 138

5.9.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PRECLINICAL IMAGING PATENTS 138

FIGURE 25 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PRECLINICAL IMAGING PATENTS, 2013–2023 138

5.9.3 MAJOR PATENTS 139

FIGURE 26 MAJOR PATENTS FOR PRECLINICAL IMAGING (2013–2023) 139

5.9.4 LIST OF PATENTS/PATENT APPLICATIONS 140

5.10 TRADE ANALYSIS 140

5.10.1 TRADE ANALYSIS FOR PRECLINICAL IMAGING SYSTEMS 141

FIGURE 27 PRODUCT IMPORTS UNDER HSN CODE 901813, BY COUNTRY, 2022 (USD THOUSAND) 141

FIGURE 28 PRODUCT EXPORTS UNDER HSN CODE 901813, BY COUNTRY, 2022 (USD THOUSAND) 142

5.11 CASE STUDY ANALYSIS 142

TABLE 16 CASE STUDY 1: PRECLINICAL DEVELOPMENT AND FIRST-IN-HUMAN STUDY OF 68GA-DOTA-MLN6907 142

TABLE 17 CASE STUDY 2: ACCELERATING PRECLINICAL ANALYSIS OF OCULAR DISEASES 143

TABLE 18 CASE STUDY 3: USAGE OF CRYO-FLUORESCENCE TOMOGRAPHY 143

5.12 KEY CONFERENCES & EVENTS, 2023–2024 144

5.13 KEY STAKEHOLDERS & BUYING CRITERIA 146

5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 146

TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRECLINICAL IMAGING SYSTEMS 146

TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRECLINICAL IMAGING SYSTEMS, BY TYPE 147

5.13.2 BUYING CRITERIA 147

FIGURE 29 KEY BUYING CRITERIA FOR PRECLINICAL IMAGING SYSTEMS, BY TYPE 147

TABLE 21 KEY BUYING CRITERIA FOR PRECLINICAL IMAGING SYSTEMS 147

5.14 UNMET NEEDS ANALYSIS 148

TABLE 22 UNMET NEEDS IN PRECLINICAL IMAGING MARKET 148

5.14.1 END-USER EXPECTATIONS 148

TABLE 23 END-USER EXPECTATIONS IN PRECLINICAL IMAGING MARKET 148

5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 149

5.16 REIMBURSEMENT SCENARIO 149

TABLE 24 US: MEDICAL REIMBURSEMENT CPT CODES FOR PRECLINICAL IMAGING PROCEDURES (AS OF 2021) 150

5.17 BUSINESS MODEL ANALYSIS 150

5.18 INVESTMENT AND FUNDING SCENARIO 151

FIGURE 31 FUNDING OF PLAYERS IN PRECLINICAL IMAGING MARKET, 2023 151

6 PRECLINICAL IMAGING MARKET, BY PRODUCT 152

6.1 INTRODUCTION 153

TABLE 25 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 153

TABLE 26 PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 153

6.2 IMAGING SYSTEMS 153

TABLE 27 PRECLINICAL IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 154

TABLE 28 PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 154

TABLE 29 PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 155

6.2.1 OPTICAL IMAGING SYSTEMS 155

TABLE 30 OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 156

TABLE 31 OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 156

6.2.1.1 Bioluminescence imaging systems 156

6.2.1.1.1 Advanced imaging techniques to propel adoption 156

TABLE 32 BIOLUMINESCENT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 157

TABLE 33 BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 158

6.2.1.2 Fluorescence imaging systems 159

6.2.1.2.1 Integration with other imaging modalities to support market growth 159

TABLE 34 FLUORESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 159

TABLE 35 FLUORESCENCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 160

6.2.1.3 Other optical imaging systems 160

TABLE 36 OTHER OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 161

TABLE 37 OTHER OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 162

6.2.2 NUCLEAR IMAGING SYSTEMS 162

TABLE 38 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 163

TABLE 39 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 163

TABLE 40 NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 164

TABLE 41 NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 165

6.2.2.1 Micro-PET imaging systems 165

TABLE 42 MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 165

TABLE 43 MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 166

TABLE 44 MICRO-PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 166

TABLE 45 MICRO-PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 167

6.2.2.1.1 Standalone PET imaging systems 167

6.2.2.1.1.1 Development of technologically advanced multimodality PET/CT imaging systems to limit market growth 167

TABLE 46 STANDALONE PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 168

TABLE 47 STANDALONE PET IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 169

6.2.2.1.2 PET/CT imaging systems 169

6.2.2.1.2.1 Expanding applications to aid market growth 169

TABLE 48 PET/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 170

TABLE 49 PET/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 171

6.2.2.1.3 PET/MRI imaging systems 171

6.2.2.1.3.1 Absence of ionizing radiations to aid market growth 171

TABLE 50 PET/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 172

TABLE 51 PET/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 173

6.2.2.2 Micro-SPECT imaging systems 173

TABLE 52 MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 174

TABLE 53 MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 174

TABLE 54 MICRO-SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 175

TABLE 55 MICRO-SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 176

6.2.2.2.1 SPECT/CT imaging systems 176

6.2.2.2.1.1 Wide applications in oncology research to drive market 176

TABLE 56 SPECT/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 177

TABLE 57 SPECT/CT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 178

6.2.2.2.2 SPECT/MRI imaging systems 178

6.2.2.2.2.1 Enhanced sensitivity to aid market growth 178

TABLE 58 SPECT/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 179

TABLE 59 SPECT/MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 180

6.2.2.2.3 Standalone SPECT imaging systems 180

6.2.2.2.3.1 Lower sensitivity and longer scan times to limit market growth 180

TABLE 60 STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 181

TABLE 61 STANDALONE SPECT IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 182

6.2.2.3 Trimodality (SPECT/PET/CT) imaging systems 182

6.2.2.3.1 High resolution of systems to drive adoption 182

TABLE 62 TRIMODALITY (SPECT/PET/CT) IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 183

TABLE 63 TRIMODALITY (SPECT/PET/CT) IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 184

6.2.3 MICRO-MRI SYSTEMS 184

6.2.3.1 Technological advancements to support market growth 184

TABLE 64 MICRO-MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 185

TABLE 65 MIRCO-MRI IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 186

6.2.4 MICRO-ULTRASOUND SYSTEMS 186

6.2.4.1 Portable and cost-effective—key factors driving their adoption 186

TABLE 66 MICRO-ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 187

TABLE 67 MICRO-ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 188

6.2.5 MICRO-CT SYSTEMS 188

6.2.5.1 Technical advancements in X-ray sources and X-ray imaging arrays to support market growth 188

TABLE 68 MICRO-CT SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 189

TABLE 69 MICRO-CT SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 190

6.2.6 PHOTOACOUSTIC IMAGING SYSTEMS 190

6.2.6.1 Rising number of research studies for development of cancer therapeutics to drive market 190

TABLE 70 PHOTOACOUSTIC IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 191

TABLE 71 PHOTOACOUSTIC IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 192

6.2.7 MAGNETIC PARTICLE IMAGING SYSTEMS 192

6.2.7.1 Exceptional spatial resolution and sensitivity to aid market growth 192

TABLE 72 MAGNETIC PARTICLE IMAGING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 193

TABLE 73 MAGNETIC PARTICLE IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 194

6.3 REAGENTS 194

TABLE 74 PRECLINICAL IMAGING REAGENTS OFFERED BY KEY MARKET PLAYERS 194

TABLE 75 PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 195

TABLE 76 PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 195

6.3.1 OPTICAL IMAGING REAGENTS 195

TABLE 77 OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 196

TABLE 78 OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 196

TABLE 79 OPTICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 197

TABLE 80 OPTICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 198

6.3.1.1 Bioluminescent imaging reagents 198

TABLE 81 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 199

TABLE 82 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 199

TABLE 83 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 200

TABLE 84 BIOLUMINESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 201

6.3.1.1.1 Luciferin 201

6.3.1.1.1.1 Used in preclinical molecular imaging of gene expression in cell cultures, individual cells, and whole organisms 201

TABLE 85 LUCIFERIN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 202

TABLE 86 LUCIFERIN MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 203

6.3.1.1.2 Coelenterazine 203

6.3.1.1.2.1 Lower bioavailability to limit market growth 203

TABLE 87 COELENTERAZINE MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 204

TABLE 88 COELENTERAZINE MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 205

6.3.1.1.3 Furimazine 205

6.3.1.1.3.1 Superior sensitivity and stability compared to traditional luciferase substrates enhance data accuracy 205

TABLE 89 FURIMAZINE MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 206

TABLE 90 FURIMAZINE MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 207

6.3.1.2 Fluorescent imaging reagents 207

TABLE 91 FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 208

TABLE 92 FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 208

TABLE 93 FLUORESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 209

TABLE 94 FLUORESCENT IMAGING REAGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 210

6.3.1.2.1 Green fluorescent proteins 210

6.3.1.2.1.1 Noninvasive visualization to drive market growth 210

TABLE 95 GREEN FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 211

TABLE 96 GREEN FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 212

6.3.1.2.2 Red fluorescent proteins 212

6.3.1.2.2.1 Growing use of RFPs in preclinical research to support market growth 212

TABLE 97 RED FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 213

TABLE 98 RED FLUORESCENT PROTEINS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 214

6.3.1.2.3 Infrared dyes 214

6.3.1.2.3.1 Advancements in infrared imaging technology to propel market 214

TABLE 99 INFRARED DYES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 215

TABLE 100 INFRARED DYES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 216

6.3.2 NUCLEAR IMAGING REAGENTS 216

TABLE 101 NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 216

TABLE 102 NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 217

TABLE 103 NUCLEAR IMAGING REAGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 217

TABLE 104 NUCLEAR IMAGING REAGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 218

6.3.2.1 PET tracers 218

TABLE 105 PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 219

TABLE 106 PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 219

TABLE 107 PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 220

TABLE 108 PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 221

6.3.2.1.1 Fluorine-18-based PET Tracers 221

6.3.2.1.1.1 Most preferred PET tracer due to longer half-life 221

TABLE 109 FLUORINE-18-BASED PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 222

TABLE 110 FLUORINE-18-BASED PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 223

6.3.2.1.2 Carbon-11-based PET Tracers 223

6.3.2.1.2.1 Shorter half-life makes syntheses and commercial distribution difficult and complex 223

TABLE 111 CARBON-11-BASED PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 224

TABLE 112 CARBON-11-BASED PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 225

6.3.2.1.3 Copper-64-based PET Tracers 225

6.3.2.1.3.1 Low initial positron energy makes it suitable for imaging 225

TABLE 113 COPPER-64-BASED PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 226

TABLE 114 COPPER-64-BASED PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 227

6.3.2.1.4 Other PET tracers 227

TABLE 115 OTHER PET TRACERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 228

TABLE 116 OTHER PET TRACERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 229

6.3.2.2 SPECT probes 229

TABLE 117 SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 230

TABLE 118 SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 230

TABLE 119 SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 231

TABLE 120 SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 232

6.3.2.2.1 Technetium-99m-based SPECT Probes 232

6.3.2.2.1.1 Wide usage in various applications to support market growth 232

TABLE 121 TECHNETIUM-99M-BASED SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 233

TABLE 122 TECHNETIUM-99M-BASED SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 234

6.3.2.2.2 Iodine-131-based SPECT Probes 234

6.3.2.2.2.1 High risk of radiation hazards limits utilization in preclinical research studies 234

TABLE 123 IODINE-131-BASED SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 235

TABLE 124 IODINE-131-BASED SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 236

6.3.2.2.3 Gallium-67-based SPECT Probes 236

6.3.2.2.3.1 Widely used in nuclear imaging to study inflammation and chronic tumors 236

TABLE 125 GALLIUM-67-BASED SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 237

TABLE 126 GALLIUM-67-BASED SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 238

6.3.2.2.4 Thallium-201-based SPECT Probes 238

6.3.2.2.4.1 Longer half-life and low radiation dose to support market growth 238

TABLE 127 THALLIUM-201-BASED SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 239

TABLE 128 THALLIUM-201-BASED SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 240

6.3.2.2.5 Other SPECT probes 240

TABLE 129 OTHER SPECT PROBES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 241

TABLE 130 OTHER SPECT PROBES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 242

6.3.3 MRI CONTRAST AGENTS 242

TABLE 131 MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 243

TABLE 132 MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 243

TABLE 133 MRI CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 244

TABLE 134 MRI CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 245

6.3.3.1 Gadolinium-based contrast agents 245

6.3.3.1.1 Rising number of research studies on neurological disorders to drive market 245

TABLE 135 GADOLINIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 246

TABLE 136 GADOLINIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 247

6.3.3.2 Iron-based contrast agents 247

6.3.3.2.1 Increasing number of research studies for development of novel cancer therapeutics to propel market 247

TABLE 137 IRON-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 248

TABLE 138 IRON-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 249

6.3.3.3 Manganese-based contrast agents 249

6.3.3.3.1 Toxicity of gadolinium-based contrast agents to drive demand 249

TABLE 139 MANGANESE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 250

TABLE 140 MANGANESE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 251

6.3.4 ULTRASOUND CONTRAST AGENTS 251

6.3.4.1 Advancements in ultrasound technology to support market growth 251

TABLE 141 ULTRASOUND CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 252

TABLE 142 ULTRASOUND CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 253

6.3.5 CT CONTRAST AGENTS 253

TABLE 143 CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 254

TABLE 144 CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 254

TABLE 145 CT CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 255

TABLE 146 CT CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 256

6.3.5.1 Iodine-based contrast agents 256

6.3.5.1.1 Advancements in CT imaging technology to drive market 256

TABLE 147 IODINE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 257

TABLE 148 IODINE-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 258

6.3.5.2 Barium-based contrast agents 258

6.3.5.2.1 Limited number of ongoing gastrointestinal research activities to hamper market growth 258

TABLE 149 BARIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 259

TABLE 150 BARIUM-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 260

6.3.5.3 Gold nanoparticles 260

6.3.5.3.1 Advantages of gold nanoparticles over other CT contrast agents to increase demand 260

TABLE 151 GOLD NANOPARTICLES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 261

TABLE 152 GOLD NANOPARTICLES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 262

6.3.5.4 Gastrografin-based contrast agents 262

6.3.5.4.1 Used for imaging of gastrointestinal tract 262

TABLE 153 GASTROGRAFIN-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 263

TABLE 154 GASTROGRAFIN-BASED CONTRAST AGENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 264

6.4 SOFTWARE 264

6.4.1 ADVANCES IN IMAGING TECHNOLOGIES NECESSITATE ADVANCED SOFTWARE FOR DATA HANDLING AND ANALYSIS 264

TABLE 155 PRECLINICAL IMAGING SOFTWARE OFFERED BY KEY MARKET PLAYERS 265

TABLE 156 PRECLINICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 265

TABLE 157 PRECLINICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 266

7 PRECLINICAL IMAGING MARKET, BY APPLICATION 267

7.1 INTRODUCTION 268

TABLE 158 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 268

TABLE 159 PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 268

7.2 ONCOLOGY 269

7.2.1 GROWING FOCUS ON DEVELOPMENT OF ONCOLOGY THERAPEUTICS TO DRIVE MARKET 269

TABLE 160 PRECLINICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2022 (USD MILLION) 269

TABLE 161 PRECLINICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2029 (USD MILLION) 270

7.3 CARDIOLOGY 270

7.3.1 INCREASED FOCUS ON TARGETED TREATMENTS FOR CVD TO PROPEL MARKET 270

TABLE 162 PRECLINICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2018–2022 (USD MILLION) 271

TABLE 163 PRECLINICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2023–2029 (USD MILLION) 272

7.4 NEUROLOGY 272

7.4.1 INCREASING PREVALENCE OF NEUROLOGICAL DISORDERS TO SUPPORT MARKET GROWTH 272

TABLE 164 PRECLINICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2018–2022 (USD MILLION) 273

TABLE 165 PRECLINICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2029 (USD MILLION) 274

7.5 INFECTIOUS DISEASES 274

7.5.1 RISING PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH 274

TABLE 166 PRECLINICAL IMAGING MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018–2022 (USD MILLION) 275

TABLE 167 PRECLINICAL IMAGING MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2029 (USD MILLION) 276

7.6 IMMUNOLOGY & INFLAMMATION 276

7.6.1 ADVANCEMENTS IN IMMUNOTHERAPY RESEARCH TO PROPEL MARKET 276

TABLE 168 PRECLINICAL IMAGING MARKET FOR IMMUNOLOGY & INFLAMMATION, BY COUNTRY, 2018–2022 (USD MILLION) 277

TABLE 169 PRECLINICAL IMAGING MARKET FOR IMMUNOLOGY & INFLAMMATION, BY COUNTRY, 2023–2029 (USD MILLION) 278

7.7 OTHER APPLICATIONS 278

TABLE 170 PRECLINICAL IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2022 (USD MILLION) 279

TABLE 171 PRECLINICAL IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION) 280

8 PRECLINICAL IMAGING MARKET, BY END USER 281

8.1 INTRODUCTION 282

TABLE 172 PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 282

TABLE 173 PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 282

8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 283

8.2.1 MAJOR END USERS DUE TO EXTENSIVE INVOLVEMENT IN DRUG DISCOVERY AND DEVELOPMENT PROCESSES 283

TABLE 174 PRECLINICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2022 (USD MILLION) 283

TABLE 175 PRECLINICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2029 (USD MILLION) 284

8.3 ACADEMIC & RESEARCH CENTERS 284

8.3.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET 284

TABLE 176 PRECLINICAL IMAGING MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2018–2022 (USD MILLION) 285

TABLE 177 PRECLINICAL IMAGING MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2023–2029 (USD MILLION) 286

8.4 IMAGING CENTERS 286

8.4.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO PROPEL MARKET 286

TABLE 178 PRECLINICAL IMAGING MARKET FOR IMAGING CENTERS, BY COUNTRY, 2018–2022 (USD MILLION) 287

TABLE 179 PRECLINICAL IMAGING MARKET FOR IMAGING CENTERS, BY COUNTRY, 2023–2029 (USD MILLION) 288

8.5 OTHER END USERS 288

TABLE 180 PRECLINICAL IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2022 (USD MILLION) 289

TABLE 181 PRECLINICAL IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2029 (USD MILLION) 290

9 PRECLINICAL IMAGING MARKET, BY REGION 291

9.1 INTRODUCTION 292

TABLE 182 PRECLINICAL IMAGING MARKET, BY REGION, 2018–2022 (USD MILLION) 292

TABLE 183 PRECLINICAL IMAGING MARKET, BY REGION, 2023–2029 (USD MILLION) 292

9.2 NORTH AMERICA 293

9.2.1 NORTH AMERICA: RECESSION IMPACT 293

FIGURE 32 NORTH AMERICA: PRECLINICAL IMAGING MARKET SNAPSHOT 294

TABLE 184 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 294

TABLE 185 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 295

TABLE 186 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 295

TABLE 187 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 295

TABLE 188 NORTH AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 296

TABLE 189 NORTH AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 296

TABLE 190 NORTH AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 297

TABLE 191 NORTH AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 297

TABLE 192 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 297

TABLE 193 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 298

TABLE 194 NORTH AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2018–2022 (USD MILLION) 298

TABLE 195 NORTH AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2023–2029 (USD MILLION) 298

TABLE 196 NORTH AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 299

TABLE 197 NORTH AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 299

TABLE 198 NORTH AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 299

TABLE 199 NORTH AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 300

TABLE 200 NORTH AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 300

TABLE 201 NORTH AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 300

TABLE 202 NORTH AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 301

TABLE 203 NORTH AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 301

TABLE 204 NORTH AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 301

TABLE 205 NORTH AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 302

TABLE 206 NORTH AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 302

TABLE 207 NORTH AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 302

TABLE 208 NORTH AMERICA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 303

TABLE 209 NORTH AMERICA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 303

TABLE 210 NORTH AMERICA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 303

TABLE 211 NORTH AMERICA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 304

TABLE 212 NORTH AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 304

TABLE 213 NORTH AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 304

TABLE 214 NORTH AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 305

TABLE 215 NORTH AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 305

TABLE 216 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 305

TABLE 217 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 306

TABLE 218 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 306

TABLE 219 NORTH AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 306

9.2.2 US 307

9.2.2.1 Rapid adoption of technologically advanced imaging systems to drive growth 307

TABLE 220 US: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 308

TABLE 221 US: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 308

TABLE 222 US: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 308

TABLE 223 US: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 309

TABLE 224 US: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 309

TABLE 225 US: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 309

TABLE 226 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 310

TABLE 227 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 310

TABLE 228 US: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 310

TABLE 229 US: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 311

TABLE 230 US: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 311

TABLE 231 US: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 311

TABLE 232 US: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 312

TABLE 233 US: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 312

TABLE 234 US: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 312

TABLE 235 US: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 313

TABLE 236 US: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 313

TABLE 237 US: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 313

TABLE 238 US: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 314

TABLE 239 US: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 314

TABLE 240 US: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 314

TABLE 241 US: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 314

TABLE 242 US: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 315

TABLE 243 US: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 315

TABLE 244 US: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 315

TABLE 245 US: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 316

TABLE 246 US: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 316

TABLE 247 US: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 316

TABLE 248 US: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 317

TABLE 249 US: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 317

TABLE 250 US: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 317

TABLE 251 US: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 318

TABLE 252 US: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 318

TABLE 253 US: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 318

9.2.3 CANADA 319

9.2.3.1 Growth in stem cell research activities to support market growth 319

TABLE 254 CANADA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 319

TABLE 255 CANADA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 319

TABLE 256 CANADA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 320

TABLE 257 CANADA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 320

TABLE 258 CANADA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 321

TABLE 259 CANADA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 321

TABLE 260 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 321

TABLE 261 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 322

TABLE 262 CANADA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 322

TABLE 263 CANADA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 322

TABLE 264 CANADA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 323

TABLE 265 CANADA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 323

TABLE 266 CANADA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 323

TABLE 267 CANADA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 324

TABLE 268 CANADA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 324

TABLE 269 CANADA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 324

TABLE 270 CANADA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 325

TABLE 271 CANADA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 325

TABLE 272 CANADA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 325

TABLE 273 CANADA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 326

TABLE 274 CANADA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 326

TABLE 275 CANADA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 326

TABLE 276 CANADA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 327

TABLE 277 CANADA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 327

TABLE 278 CANADA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 327

TABLE 279 CANADA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 328

TABLE 280 CANADA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 328

TABLE 281 CANADA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 328

TABLE 282 CANADA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 329

TABLE 283 CANADA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 329

TABLE 284 CANADA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 329

TABLE 285 CANADA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 330

TABLE 286 CANADA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 330

TABLE 287 CANADA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 330

9.3 EUROPE 331

9.3.1 EUROPE: RECESSION IMPACT 331

TABLE 288 EUROPE: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 331

TABLE 289 EUROPE: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 332

TABLE 290 EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 332

TABLE 291 EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 332

TABLE 292 EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 333

TABLE 293 EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 333

TABLE 294 EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 334

TABLE 295 EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 334

TABLE 296 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 334

TABLE 297 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 335

TABLE 298 EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 335

TABLE 299 EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 335

TABLE 300 EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 336

TABLE 301 EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 336

TABLE 302 EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 336

TABLE 303 EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 337

TABLE 304 EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 337

TABLE 305 EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 337

TABLE 306 EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 338

TABLE 307 EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 338

TABLE 308 EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 338

TABLE 309 EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 339

TABLE 310 EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 339

TABLE 311 EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 339

TABLE 312 EUROPE: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 340

TABLE 313 EUROPE: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 340

TABLE 314 EUROPE: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 340

TABLE 315 EUROPE: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 341

TABLE 316 EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 341

TABLE 317 EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 341

TABLE 318 EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 342

TABLE 319 EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 342

TABLE 320 EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 342

TABLE 321 EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 343

TABLE 322 EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 343

TABLE 323 EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 343

9.3.2 GERMANY 344

9.3.2.1 Growth in biotechnology industry to propel market 344

TABLE 324 GERMANY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 344

TABLE 325 GERMANY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 345

TABLE 326 GERMANY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 345

TABLE 327 GERMANY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 346

TABLE 328 GERMANY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 346

TABLE 329 GERMANY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 347

TABLE 330 GERMANY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 347

TABLE 331 GERMANY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 347

TABLE 332 GERMANY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 348

TABLE 333 GERMANY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 348

TABLE 334 GERMANY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 348

TABLE 335 GERMANY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 349

TABLE 336 GERMANY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 349

TABLE 337 GERMANY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 349

TABLE 338 GERMANY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 350

TABLE 339 GERMANY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 350

TABLE 340 GERMANY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 350

TABLE 341 GERMANY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 351

TABLE 342 GERMANY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 351

TABLE 343 GERMANY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 351

TABLE 344 GERMANY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 352

TABLE 345 GERMANY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 352

TABLE 346 GERMANY: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 352

TABLE 347 GERMANY: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 353

TABLE 348 GERMANY: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 353

TABLE 349 GERMANY: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 354

TABLE 350 GERMANY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 354

TABLE 351 GERMANY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 354

TABLE 352 GERMANY: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 355

TABLE 353 GERMANY: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 355

TABLE 354 GERMANY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 355

TABLE 355 GERMANY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 356

TABLE 356 GERMANY: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 356

TABLE 357 GERMANY: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 356

9.3.3 UK 357

9.3.3.1 Increasing focus on cancer research to drive market 357

TABLE 358 UK: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 357

TABLE 359 UK: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 357

TABLE 360 UK: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 358

TABLE 361 UK: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 358

TABLE 362 UK: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 359

TABLE 363 UK: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 359

TABLE 364 UK: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 359

TABLE 365 UK: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 360

TABLE 366 UK: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 360

TABLE 367 UK: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 360

TABLE 368 UK: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 361

TABLE 369 UK: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 361

TABLE 370 UK: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 361

TABLE 371 UK: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 362

TABLE 372 UK: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 362

TABLE 373 UK: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 362

TABLE 374 UK: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 363

TABLE 375 UK: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 363

TABLE 376 UK: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 363

TABLE 377 UK: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 364

TABLE 378 UK: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 364

TABLE 379 UK: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 364

TABLE 380 UK: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 365

TABLE 381 UK: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 365

TABLE 382 UK: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 365

TABLE 383 UK: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 366

TABLE 384 UK: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 366

TABLE 385 UK: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 366

TABLE 386 UK: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 367

TABLE 387 UK: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 367

TABLE 388 UK: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 367

TABLE 389 UK: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 368

TABLE 390 UK: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 368

TABLE 391 UK: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 368

9.3.4 FRANCE 369

9.3.4.1 Increased investments in proteomics and genomics to fuel market growth 369

TABLE 392 FRANCE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 369

TABLE 393 FRANCE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 369

TABLE 394 FRANCE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 370

TABLE 395 FRANCE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 370

TABLE 396 FRANCE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 371

TABLE 397 FRANCE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 371

TABLE 398 FRANCE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 371

TABLE 399 FRANCE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 372

TABLE 400 FRANCE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 372

TABLE 401 FRANCE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 372

TABLE 402 FRANCE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 373

TABLE 403 FRANCE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 373

TABLE 404 FRANCE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 373

TABLE 405 FRANCE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 374

TABLE 406 FRANCE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 374

TABLE 407 FRANCE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 374

TABLE 408 FRANCE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 375

TABLE 409 FRANCE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 375

TABLE 410 FRANCE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 375

TABLE 411 FRANCE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 376

TABLE 412 FRANCE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 376

TABLE 413 FRANCE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 376

TABLE 414 FRANCE: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 377

TABLE 415 FRANCE: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 377

TABLE 416 FRANCE: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 377

TABLE 417 FRANCE: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 378

TABLE 418 FRANCE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 378

TABLE 419 FRANCE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 378

TABLE 420 FRANCE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 379

TABLE 421 FRANCE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 379

TABLE 422 FRANCE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 379

TABLE 423 FRANCE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 380

TABLE 424 FRANCE: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 380

TABLE 425 FRANCE: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 380

9.3.5 ITALY 381

9.3.5.1 Growth in biotechnology and pharmaceutical industries to drive market 381

TABLE 426 ITALY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 381

TABLE 427 ITALY: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 381

TABLE 428 ITALY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 382

TABLE 429 ITALY: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 382

TABLE 430 ITALY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 383

TABLE 431 ITALY: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 383

TABLE 432 ITALY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 383

TABLE 433 ITALY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 384

TABLE 434 ITALY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 384

TABLE 435 ITALY: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 384

TABLE 436 ITALY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 385

TABLE 437 ITALY: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 385

TABLE 438 ITALY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 385

TABLE 439 ITALY: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 386

TABLE 440 ITALY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 386

TABLE 441 ITALY: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 386

TABLE 442 ITALY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 387

TABLE 443 ITALY: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 387

TABLE 444 ITALY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 387

TABLE 445 ITALY: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 388

TABLE 446 ITALY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 388

TABLE 447 ITALY: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 388

TABLE 448 ITALY: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 389

TABLE 449 ITALY: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 389

TABLE 450 ITALY: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 389

TABLE 451 ITALY: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 390

TABLE 452 ITALY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 390

TABLE 453 ITALY: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 390

TABLE 454 ITALY: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 391

TABLE 455 ITALY: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 391

TABLE 456 ITALY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 391

TABLE 457 ITALY: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 392

TABLE 458 ITALY: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 392

TABLE 459 ITALY: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 392

9.3.6 SPAIN 393

9.3.6.1 Extensive R&D pipeline to support market growth 393

TABLE 460 SPAIN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 393

TABLE 461 SPAIN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 393

TABLE 462 SPAIN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 394

TABLE 463 SPAIN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 394

TABLE 464 SPAIN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 395

TABLE 465 SPAIN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 395

TABLE 466 SPAIN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 395

TABLE 467 SPAIN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 396

TABLE 468 SPAIN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 396

TABLE 469 SPAIN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 396

TABLE 470 SPAIN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 397

TABLE 471 SPAIN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 397

TABLE 472 SPAIN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 397

TABLE 473 SPAIN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 398

TABLE 474 SPAIN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 398

TABLE 475 SPAIN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 398

TABLE 476 SPAIN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 399

TABLE 477 SPAIN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 399

TABLE 478 SPAIN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 399

TABLE 479 SPAIN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 400

TABLE 480 SPAIN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 400

TABLE 481 SPAIN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 400

TABLE 482 SPAIN: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 401

TABLE 483 SPAIN: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 401

TABLE 484 SPAIN: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 401

TABLE 485 SPAIN: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 402

TABLE 486 SPAIN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 402

TABLE 487 SPAIN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 402

TABLE 488 SPAIN: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 403

TABLE 489 SPAIN: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 403

TABLE 490 SPAIN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 403

TABLE 491 SPAIN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 404

TABLE 492 SPAIN: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 404

TABLE 493 SPAIN: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 404

9.3.7 REST OF EUROPE 405

TABLE 494 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 405

TABLE 495 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 406

TABLE 496 REST OF EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 406

TABLE 497 REST OF EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 407

TABLE 498 REST OF EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 407

TABLE 499 REST OF EUROPE: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 408

TABLE 500 REST OF EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 408

TABLE 501 REST OF EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 408

TABLE 502 REST OF EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2018–2022 (USD MILLION) 409

TABLE 503 REST OF EUROPE: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE 2023–2029 (USD MILLION) 409

TABLE 504 REST OF EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 409

TABLE 505 REST OF EUROPE: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 410

TABLE 506 REST OF EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 410

TABLE 507 REST OF EUROPE: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 410

TABLE 508 REST OF EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 411

TABLE 509 REST OF EUROPE: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 411

TABLE 510 REST OF EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 411

TABLE 511 REST OF EUROPE: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 412

TABLE 512 REST OF EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 412

TABLE 513 REST OF EUROPE: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 412

TABLE 514 REST OF EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 413

TABLE 515 REST OF EUROPE: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 413

TABLE 516 REST OF EUROPE: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 413

TABLE 517 REST OF EUROPE: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 414

TABLE 518 REST OF EUROPE: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 414

TABLE 519 REST OF EUROPE: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 415

TABLE 520 REST OF EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 415

TABLE 521 REST OF EUROPE: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 415

TABLE 522 REST OF EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 416

TABLE 523 REST OF EUROPE: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 416

TABLE 524 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 416

TABLE 525 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 417

TABLE 526 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 417

TABLE 527 REST OF EUROPE: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 418

9.4 ASIA PACIFIC 418

9.4.1 ASIA PACIFIC: RECESSION IMPACT 418

FIGURE 33 ASIA PACIFIC: PRECLINICAL IMAGING MARKET SNAPSHOT 419

TABLE 528 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 419

TABLE 529 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 420

TABLE 530 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 420

TABLE 531 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 420

TABLE 532 ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 421

TABLE 533 ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 421

TABLE 534 ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 422

TABLE 535 ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 422

TABLE 536 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 422

TABLE 537 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 423

TABLE 538 ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 423

TABLE 539 ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 423

TABLE 540 ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 424

TABLE 541 ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 424

TABLE 542 ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 424

TABLE 543 ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 425

TABLE 544 ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 425

TABLE 545 ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 425

TABLE 546 ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 426

TABLE 547 ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 426

TABLE 548 ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 426

TABLE 549 ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 427

TABLE 550 ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 427

TABLE 551 ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 427

TABLE 552 ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 428

TABLE 553 ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 428

TABLE 554 ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 428

TABLE 555 ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 429

TABLE 556 ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 429

TABLE 557 ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 429

TABLE 558 ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 430

TABLE 559 ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 430

TABLE 560 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 430

TABLE 561 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 431

TABLE 562 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 431

TABLE 563 ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 431

9.4.2 JAPAN 432

9.4.2.1 Increasing focus on personalized diagnostic products to support market growth 432

TABLE 564 JAPAN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 432

TABLE 565 JAPAN: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 432

TABLE 566 JAPAN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 433

TABLE 567 JAPAN: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 433

TABLE 568 JAPAN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 434

TABLE 569 JAPAN: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 434

TABLE 570 JAPAN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 434

TABLE 571 JAPAN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 435

TABLE 572 JAPAN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 435

TABLE 573 JAPAN: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 435

TABLE 574 JAPAN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 436

TABLE 575 JAPAN: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 436

TABLE 576 JAPAN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 436

TABLE 577 JAPAN: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 437

TABLE 578 JAPAN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 437

TABLE 579 JAPAN: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 437

TABLE 580 JAPAN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 438

TABLE 581 JAPAN: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 438

TABLE 582 JAPAN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 438

TABLE 583 JAPAN: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 439

TABLE 584 JAPAN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 439

TABLE 585 JAPAN: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 439

TABLE 586 JAPAN: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 440

TABLE 587 JAPAN: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 440

TABLE 588 JAPAN: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 440

TABLE 589 JAPAN: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 441

TABLE 590 JAPAN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 441

TABLE 591 JAPAN: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 441

TABLE 592 JAPAN: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 442

TABLE 593 JAPAN: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 442

TABLE 594 JAPAN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 442

TABLE 595 JAPAN: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 443

TABLE 596 JAPAN: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 443

TABLE 597 JAPAN: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 443

9.4.3 CHINA 444

9.4.3.1 Fastest-growing pharmaceutical market—key factor driving market 444

TABLE 598 CHINA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 444

TABLE 599 CHINA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 444

TABLE 600 CHINA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 445

TABLE 601 CHINA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 445

TABLE 602 CHINA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 446

TABLE 603 CHINA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 446

TABLE 604 CHINA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 446

TABLE 605 CHINA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 447

TABLE 606 CHINA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 447

TABLE 607 CHINA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 447

TABLE 608 CHINA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 448

TABLE 609 CHINA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 448

TABLE 610 CHINA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 448

TABLE 611 CHINA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 449

TABLE 612 CHINA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 449

TABLE 613 CHINA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 449

TABLE 614 CHINA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 450

TABLE 615 CHINA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 450

TABLE 616 CHINA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 450

TABLE 617 CHINA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 451

TABLE 618 CHINA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 451

TABLE 619 CHINA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 451

TABLE 620 CHINA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 452

TABLE 621 CHINA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 452

TABLE 622 CHINA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 452

TABLE 623 CHINA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 453

TABLE 624 CHINA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 453

TABLE 625 CHINA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 453

TABLE 626 CHINA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 454

TABLE 627 CHINA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 454

TABLE 628 CHINA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 454

TABLE 629 CHINA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 455

TABLE 630 CHINA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 455

TABLE 631 CHINA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 455

9.4.4 INDIA 456

9.4.4.1 Favorable government policies to propel market 456

TABLE 632 INDIA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 456

TABLE 633 INDIA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 456

TABLE 634 INDIA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 457

TABLE 635 INDIA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 457

TABLE 636 INDIA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 458

TABLE 637 INDIA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 458

TABLE 638 INDIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 458

TABLE 639 INDIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 459

TABLE 640 INDIA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 459

TABLE 641 INDIA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 459

TABLE 642 INDIA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 460

TABLE 643 INDIA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 460

TABLE 644 INDIA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 460

TABLE 645 INDIA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 461

TABLE 646 INDIA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 461

TABLE 647 INDIA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 461

TABLE 648 INDIA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 462

TABLE 649 INDIA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 462

TABLE 650 INDIA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 462

TABLE 651 INDIA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 463

TABLE 652 INDIA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 463

TABLE 653 INDIA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 463

TABLE 654 INDIA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 464

TABLE 655 INDIA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 464

TABLE 656 INDIA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 464

TABLE 657 INDIA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 465

TABLE 658 INDIA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 465

TABLE 659 INDIA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 465

TABLE 660 INDIA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 466

TABLE 661 INDIA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 466

TABLE 662 INDIA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 466

TABLE 663 INDIA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 467

TABLE 664 INDIA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 467

TABLE 665 INDIA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 467

9.4.5 REST OF ASIA PACIFIC 468

TABLE 666 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 468

TABLE 667 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 468

TABLE 668 REST OF ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 469

TABLE 669 REST OF ASIA PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 469

TABLE 670 REST OF ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 470

TABLE 671 REST OF ASIA PACIFIC: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 470

TABLE 672 REST OF ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 470

TABLE 673 REST OF ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 471

TABLE 674 REST OF ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 471

TABLE 675 REST OF ASIA PACIFIC: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 471

TABLE 676 REST OF ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 472

TABLE 677 REST OF ASIA PACIFIC: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 472

TABLE 678 REST OF ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 472

TABLE 679 REST OF ASIA PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 473

TABLE 680 REST OF ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 473

TABLE 681 REST OF ASIA PACIFIC: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 473

TABLE 682 REST OF ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 474

TABLE 683 REST OF ASIA PACIFIC: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 474

TABLE 684 REST OF ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 474

TABLE 685 REST OF ASIA PACIFIC: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 475

TABLE 686 REST OF ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 475

TABLE 687 REST OF ASIA PACIFIC: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 475

TABLE 688 REST OF ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 476

TABLE 689 REST OF ASIA PACIFIC: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 476

TABLE 690 REST OF ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 476

TABLE 691 REST OF ASIA PACIFIC: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 477

TABLE 692 REST OF ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 477

TABLE 693 REST OF ASIA PACIFIC: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 477

TABLE 694 REST OF ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 478

TABLE 695 REST OF ASIA PACIFIC: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 478

TABLE 696 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 478

TABLE 697 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 479

TABLE 698 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 479

TABLE 699 REST OF ASIA PACIFIC: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 480

9.5 LATIN AMERICA 480

9.5.1 LATIN AMERICA: RECESSION IMPACT 480

TABLE 700 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 481

TABLE 701 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 481

TABLE 702 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 481

TABLE 703 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 482

TABLE 704 LATIN AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 482

TABLE 705 LATIN AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 483

TABLE 706 LATIN AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 483

TABLE 707 LATIN AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 484

TABLE 708 LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 484

TABLE 709 LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 484

TABLE 710 LATIN AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 485

TABLE 711 LATIN AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 485

TABLE 712 LATIN AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 485

TABLE 713 LATIN AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 486

TABLE 714 LATIN AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 486

TABLE 715 LATIN AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 486

TABLE 716 LATIN AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 487

TABLE 717 LATIN AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 487

TABLE 718 LATIN AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 487

TABLE 719 LATIN AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 488

TABLE 720 LATIN AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 488

TABLE 721 LATIN AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 488

TABLE 722 LATIN AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 489

TABLE 723 LATIN AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 489

TABLE 724 LATIN AMERICA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 489

TABLE 725 LATIN AMERICA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 490

TABLE 726 LATIN AMERICA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 490

TABLE 727 LATIN AMERICA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 491

TABLE 728 LATIN AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 491

TABLE 729 LATIN AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 491

TABLE 730 LATIN AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 492

TABLE 731 LATIN AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 492

TABLE 732 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 492

TABLE 733 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 493

TABLE 734 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 493

TABLE 735 LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 493

9.5.2 BRAZIL 494

9.5.2.1 Increasing Investments in Biopharmaceutical research to propel market 494

TABLE 736 BRAZIL: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 494

TABLE 737 BRAZIL: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 494

TABLE 738 BRAZIL: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 495

TABLE 739 BRAZIL: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 495

TABLE 740 BRAZIL: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 496

TABLE 741 BRAZIL: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 496

TABLE 742 BRAZIL: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 496

TABLE 743 BRAZIL: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 497

TABLE 744 BRAZIL: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 497

TABLE 745 BRAZIL: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 497

TABLE 746 BRAZIL: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 498

TABLE 747 BRAZIL: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 498

TABLE 748 BRAZIL: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 498

TABLE 749 BRAZIL: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 499

TABLE 750 BRAZIL: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 499

TABLE 751 BRAZIL: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 499

TABLE 752 BRAZIL: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 500

TABLE 753 BRAZIL: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 500

TABLE 754 BRAZIL: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 500

TABLE 755 BRAZIL: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 501

TABLE 756 BRAZIL: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 501

TABLE 757 BRAZIL: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 501

TABLE 758 BRAZIL: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 502

TABLE 759 BRAZIL: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 502

TABLE 760 BRAZIL: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 502

TABLE 761 BRAZIL: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 503

TABLE 762 BRAZIL: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 503

TABLE 763 BRAZIL: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 503

TABLE 764 BRAZIL: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 504

TABLE 765 BRAZIL: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 504

TABLE 766 BRAZIL: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 504

TABLE 767 BRAZIL: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 505

TABLE 768 BRAZIL: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 505

TABLE 769 BRAZIL: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 505

9.5.3 MEXICO 506

9.5.3.1 Booming pharmaceutical and biotechnology industry to drive market 506

TABLE 770 MEXICO: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 506

TABLE 771 MEXICO: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 506

TABLE 772 MEXICO: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 507

TABLE 773 MEXICO: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 507

TABLE 774 MEXICO: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 508

TABLE 775 MEXICO: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 508

TABLE 776 MEXICO: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 508

TABLE 777 MEXICO: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 509

TABLE 778 MEXICO: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 509

TABLE 779 MEXICO: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 509

TABLE 780 MEXICO: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 510

TABLE 781 MEXICO: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 510

TABLE 782 MEXICO: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 510

TABLE 783 MEXICO: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 511

TABLE 784 MEXICO: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 511

TABLE 785 MEXICO: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 511

TABLE 786 MEXICO: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 512

TABLE 787 MEXICO: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 512

TABLE 788 MEXICO: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 512

TABLE 789 MEXICO: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 513

TABLE 790 MEXICO: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 513

TABLE 791 MEXICO: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 513

TABLE 792 MEXICO: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 514

TABLE 793 MEXICO: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 514

TABLE 794 MEXICO: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 514

TABLE 795 MEXICO: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 515

TABLE 796 MEXICO: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 515

TABLE 797 MEXICO: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 515

TABLE 798 MEXICO: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 516

TABLE 799 MEXICO: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 516

TABLE 800 MEXICO: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 516

TABLE 801 MEXICO: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 517

TABLE 802 MEXICO: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 517

TABLE 803 MEXICO: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 517

9.5.4 REST OF LATIN AMERICA 518

TABLE 804 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 518

TABLE 805 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 518

TABLE 806 REST OF LATIN AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 519

TABLE 807 REST OF LATIN AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 519

TABLE 808 REST OF LATIN AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 520

TABLE 809 REST OF LATIN AMERICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 520

TABLE 810 REST OF LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 520

TABLE 811 REST OF LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 521

TABLE 812 REST OF LATIN AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 521

TABLE 813 REST OF LATIN AMERICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 521

TABLE 814 REST OF LATIN AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 522

TABLE 815 REST OF LATIN AMERICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 522

TABLE 816 REST OF LATIN AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 522

TABLE 817 REST OF LATIN AMERICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 523

TABLE 818 REST OF LATIN AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 523

TABLE 819 REST OF LATIN AMERICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 523

TABLE 820 REST OF LATIN AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 524

TABLE 821 REST OF LATIN AMERICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 524

TABLE 822 REST OF LATIN AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 524

TABLE 823 REST OF LATIN AMERICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 525

TABLE 824 REST OF LATIN AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 525

TABLE 825 REST OF LATIN AMERICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 525

TABLE 826 REST OF LATIN AMERICA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 526

TABLE 827 REST OF LATIN AMERICA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 526

TABLE 828 REST OF LATIN AMERICA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 526

TABLE 829 REST OF LATIN AMERICA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 527

TABLE 830 REST OF LATIN AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 527

TABLE 831 REST OF LATIN AMERICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 527

TABLE 832 REST OF LATIN AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 528

TABLE 833 REST OF LATIN AMERICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 528

TABLE 834 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 528

TABLE 835 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 529

TABLE 836 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 529

TABLE 837 REST OF LATIN AMERICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 530

9.6 MIDDLE EAST & AFRICA 530

9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 530

TABLE 838 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 531

TABLE 839 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 531

TABLE 840 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 531

TABLE 841 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 532

TABLE 842 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 532

TABLE 843 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 533

TABLE 844 MIDDLE EAST & AFRICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 533

TABLE 845 MIDDLE EAST & AFRICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 534

TABLE 846 MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 534

TABLE 847 MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 534

TABLE 848 MIDDLE EAST & AFRICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 535

TABLE 849 MIDDLE EAST & AFRICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 535

TABLE 850 MIDDLE EAST & AFRICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 535

TABLE 851 MIDDLE EAST & AFRICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 536

TABLE 852 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 536

TABLE 853 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 536

TABLE 854 MIDDLE EAST & AFRICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 537

TABLE 855 MIDDLE EAST & AFRICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 537

TABLE 856 MIDDLE EAST & AFRICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 537

TABLE 857 MIDDLE EAST & AFRICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 538

TABLE 858 MIDDLE EAST & AFRICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 538

TABLE 859 MIDDLE EAST & AFRICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 538

TABLE 860 MIDDLE EAST & AFRICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 539

TABLE 861 MIDDLE EAST & AFRICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 539

TABLE 862 MIDDLE EAST & AFRICA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 539

TABLE 863 MIDDLE EAST & AFRICA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 540

TABLE 864 MIDDLE EAST & AFRICA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 540

TABLE 865 MIDDLE EAST & AFRICA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 541

TABLE 866 MIDDLE EAST & AFRICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 541

TABLE 867 MIDDLE EAST & AFRICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 541

TABLE 868 MIDDLE EAST & AFRICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 542

TABLE 869 MIDDLE EAST & AFRICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 542

TABLE 870 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 542

TABLE 871 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 543

TABLE 872 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 543

TABLE 873 MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 543

9.6.2 GCC COUNTRIES 544

9.6.2.1 Increasing research activities to support market growth 544

TABLE 874 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 544

TABLE 875 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 544

TABLE 876 GCC COUNTRIES: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 545

TABLE 877 GCC COUNTRIES: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 545

TABLE 878 GCC COUNTRIES: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 546

TABLE 879 GCC COUNTRIES: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 546

TABLE 880 GCC COUNTRIES: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 546

TABLE 881 GCC COUNTRIES: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 547

TABLE 882 GCC COUNTRIES: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 547

TABLE 883 GCC COUNTRIES: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 547

TABLE 884 GCC COUNTRIES: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 548

TABLE 885 GCC COUNTRIES: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 548

TABLE 886 GCC COUNTRIES: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 548

TABLE 887 GCC COUNTRIES: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 549

TABLE 888 GCC COUNTRIES: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 549

TABLE 889 GCC COUNTRIES: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 549

TABLE 890 GCC COUNTRIES: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 550

TABLE 891 GCC COUNTRIES: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 550

TABLE 892 GCC COUNTRIES: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 550

TABLE 893 GCC COUNTRIES: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 551

TABLE 894 GCC COUNTRIES: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 551

TABLE 895 GCC COUNTRIES: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 551

TABLE 896 GCC COUNTRIES: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 552

TABLE 897 GCC COUNTRIES: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 552

TABLE 898 GCC COUNTRIES: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 552

TABLE 899 GCC COUNTRIES: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 553

TABLE 900 GCC COUNTRIES: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 553

TABLE 901 GCC COUNTRIES: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 553

TABLE 902 GCC COUNTRIES: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 554

TABLE 903 GCC COUNTRIES: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 554

TABLE 904 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 554

TABLE 905 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 555

TABLE 906 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 555

TABLE 907 GCC COUNTRIES: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 555

9.6.3 REST OF MIDDLE EAST & AFRICA 556

TABLE 908 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2018–2022 (USD MILLION) 556

TABLE 909 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY PRODUCT, 2023–2029 (USD MILLION) 556

TABLE 910 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 557

TABLE 911 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 557

TABLE 912 REST OF MIDDLE EAST & AFRICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 558

TABLE 913 REST OF MIDDLE EAST & AFRICA: OPTICAL IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 558

TABLE 914 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 558

TABLE 915 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 559

TABLE 916 REST OF MIDDLE EAST & AFRICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 559

TABLE 917 REST OF MIDDLE EAST & AFRICA: MICRO-PET IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 559

TABLE 918 REST OF MIDDLE EAST & AFRICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 560

TABLE 919 REST OF MIDDLE EAST & AFRICA: MICRO-SPECT IMAGING SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 560

TABLE 920 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 560

TABLE 921 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 561

TABLE 922 REST OF MIDDLE EAST & AFRICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 561

TABLE 923 REST OF MIDDLE EAST & AFRICA: OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 561

TABLE 924 REST OF MIDDLE EAST & AFRICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 562

TABLE 925 REST OF MIDDLE EAST & AFRICA: BIOLUMINESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 562

TABLE 926 REST OF MIDDLE EAST & AFRICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 562

TABLE 927 REST OF MIDDLE EAST & AFRICA: FLUORESCENT IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 563

TABLE 928 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 563

TABLE 929 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 563

TABLE 930 REST OF MIDDLE EAST & AFRICA: PET TRACERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 564

TABLE 931 REST OF MIDDLE EAST & AFRICA: PET TRACERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 564

TABLE 932 REST OF MIDDLE EAST & AFRICA: SPECT PROBES MARKET, BY TYPE, 2018–2022 (USD MILLION) 564

TABLE 933 REST OF MIDDLE EAST & AFRICA: SPECT PROBES MARKET, BY TYPE, 2023–2029 (USD MILLION) 565

TABLE 934 REST OF MIDDLE EAST & AFRICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 565

TABLE 935 REST OF MIDDLE EAST & AFRICA: MRI CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 565

TABLE 936 REST OF MIDDLE EAST & AFRICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 566

TABLE 937 REST OF MIDDLE EAST & AFRICA: CT CONTRAST AGENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 566

TABLE 938 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 566

TABLE 939 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 567

TABLE 940 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY END USER, 2018–2022 (USD MILLION) 567

TABLE 941 REST OF MIDDLE EAST & AFRICA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION) 567

10 COMPETITIVE LANDSCAPE 568

10.1 OVERVIEW 568

10.2 KEY PLAYER STRATEGY/ RIGHT TO WIN 568

10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PRECLINICAL IMAGING MARKET 569

FIGURE 34 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES 569

10.3 REVENUE ANALYSIS 570

FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN PRECLINICAL IMAGING MARKET, 2019–2023 (USD MILLION) 570

10.4 MARKET SHARE ANALYSIS 570

FIGURE 36 PRECLINICAL IMAGING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023 570

TABLE 942 PRECLINICAL IMAGING MARKET: DEGREE OF COMPETITION 571

10.5 RANKING OF KEY MARKET PLAYERS 572

FIGURE 37 RANKING OF KEY PLAYERS IN THE PRECLINICAL IMAGING MARKET, 2023 572

10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 572

10.6.1 STARS 572

10.6.2 EMERGING LEADERS 572

10.6.3 PERVASIVE PLAYERS 574

10.6.4 PARTICIPANTS 574

FIGURE 38 PRECLINICAL IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 574

10.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 575

10.6.5.1 Company footprint 575

TABLE 943 PRECLINICAL IMAGING MARKET: COMPANY FOOTPRINT 575

10.6.5.2 Product footprint 576

TABLE 944 PRECLINICAL IMAGING MARKET: PRODUCT FOOTPRINT 576

10.6.5.3 Application footprint 577

TABLE 945 PRECLINICAL IMAGING MARKET: APPLICATION FOOTPRINT 577

10.6.5.4 End-user footprint 578

TABLE 946 PRECLINICAL IMAGING MARKET: END-USER FOOTPRINT 578

10.6.5.5 Region footprint 579

TABLE 947 PRECLINICAL IMAGING MARKET: REGION FOOTPRINT 579

10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 579

10.7.1 PROGRESSIVE COMPANIES 579

10.7.2 RESPONSIVE COMPANIES 580

10.7.3 DYNAMIC COMPANIES 580

10.7.4 STARTING BLOCKS 580

FIGURE 39 PRECLINICAL IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 580

10.7.5 COMPETITIVE BENCHMARKING: STARTUP/SME PLAYERS 581

TABLE 948 PRECLINICAL IMAGING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 581

TABLE 949 PRECLINICAL IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING STARTUPS/SMES 581

10.8 VALUATION AND FINANCIAL METRICS 582

FIGURE 40 EV/EBITDA OF KEY VENDORS 582

FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 582

10.9 BRAND/PRODUCT COMPARISON 583

FIGURE 42 PRECLINICAL IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 583

10.10 COMPETITIVE SCENARIO 584

10.10.1 PRODUCT LAUNCHES 584

TABLE 950 PRECLINICAL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 584

10.10.2 DEALS 585

TABLE 951 PRECLINICAL IMAGING MARKET: DEALS, JANUARY 2021–MAY 2024 585

10.10.3 EXPANSIONS 585

TABLE 952 PRECLINICAL IMAGING MARKET: EXPANSIONS, JANUARY 2021–MAY 2024 585

11 COMPANY PROFILES 586

11.1 KEY PLAYERS 586

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

11.1.1 BRUKER CORPORATION 586

TABLE 953 BRUKER CORPORATION: COMPANY OVERVIEW 586

FIGURE 43 BRUKER CORPORATION: COMPANY SNAPSHOT (2023) 587

TABLE 954 BRUKER CORPORATION: PRODUCTS OFFERED 587

TABLE 955 BRUKER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 589

TABLE 956 BRUKER CORPORATION: DEALS, JANUARY 2021–MAY 2024 589

11.1.2 REVVITY, INC. 591

TABLE 957 REVVITY, INC.: COMPANY OVERVIEW 591

FIGURE 44 REVVITY, INC.: COMPANY SNAPSHOT (2023) 592

TABLE 958 REVVITY, INC.: PRODUCTS OFFERED 592

TABLE 959 REVVITY, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 593

11.1.3 OPTISCAN IMAGING LTD. 595

TABLE 960 OPTISCAN IMAGING LTD.: COMPANY OVERVIEW 595

FIGURE 45 OPTISCAN IMAGING LTD.: COMPANY SNAPSHOT (2023) 595

TABLE 961 OPTISCAN IMAGING LTD.: PRODUCTS OFFERED 596

11.1.4 MEDISO LTD. 597

TABLE 962 MEDISO LTD.: COMPANY OVERVIEW 597

TABLE 963 MEDISO LTD.: PRODUCTS OFFERED 597

TABLE 964 MEDISO LTD.: EXPANSIONS, JANUARY 2021–MAY 2024 598

11.1.5 ASPECT IMAGING LTD. 599

TABLE 965 ASPECT IMAGING LTD.: COMPANY OVERVIEW 599

TABLE 966 ASPECT IMAGING LTD.: PRODUCTS OFFERED 599

11.1.6 MR SOLUTIONS 601

TABLE 967 MR SOLUTIONS: COMPANY OVERVIEW 601

TABLE 968 MR SOLUTIONS: PRODUCTS OFFERED 601

11.1.7 TRIFOIL IMAGING 602

TABLE 969 TRIFOIL IMAGING: COMPANY OVERVIEW 602

TABLE 970 TRIFOIL IMAGING: PRODUCTS OFFERED 602

11.1.8 MILABS B.V. 603

TABLE 971 MILABS B.V.: COMPANY OVERVIEW 603

TABLE 972 MILABS B.V.: PRODUCTS OFFERED 603

TABLE 973 MILABS B.V.: DEALS, JANUARY 2021–MAY 2024 604

11.1.9 CUBRESA INC. 605

TABLE 974 CUBRESA INC.: COMPANY OVERVIEW 605

TABLE 975 CUBRESA INC.: PRODUCTS OFFERED 605

11.1.10 BERTHOLD TECHNOLOGIES GMBH & CO. KG 606

TABLE 976 BERTHOLD TECHNOLOGIES GMBH & CO. KG: COMPANY OVERVIEW 606

TABLE 977 BERTHOLD TECHNOLOGIES GMBH & CO. KG: PRODUCTS OFFERED 606

11.1.11 ADVANCED MOLECULAR VISION, INC. 607

TABLE 978 ADVANCED MOLECULAR VISION, INC.: COMPANY OVERVIEW 607

TABLE 979 ADVANCED MOLECULAR VISION, INC.: PRODUCTS OFFERED 607

11.1.12 SOFIE 608

TABLE 980 SOFIE: COMPANY OVERVIEW 608

TABLE 981 SOFIE: PRODUCTS OFFERED 608

11.1.13 ICONEUS 609

TABLE 982 ICONEUS: COMPANY OVERVIEW 609

TABLE 983 ICONEUS: PRODUCTS OFFERED 609

11.1.14 FUJIFILM VISUALSONICS, INC. 610

TABLE 984 FUJIFILM VISUALSONICS, INC.: COMPANY OVERVIEW 610

TABLE 985 FUJIFILM VISUALSONICS, INC.: PRODUCTS OFFERED 610

TABLE 986 FUJIFILM VISUALSONICS, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 611

TABLE 987 FUJIFILM VISUALSONICS, INC.: DEALS, JANUARY 2021–MAY 2024 611

11.1.15 LI-COR BIOTECH, LLC 612

TABLE 988 LI-COR BIOTECH, LLC: COMPANY OVERVIEW 612

TABLE 989 LI-COR BIOTECH, LLC: PRODUCTS OFFERED 612

11.1.16 IVIM TECHNOLOGY CORP. 613

TABLE 990 IVIM TECHNOLOGY CORP.: COMPANY OVERVIEW 613

TABLE 991 IVIM TECHNOLOGY CORP.: PRODUCTS OFFERED 613

11.1.17 KUB TECHNOLOGIES 614

TABLE 992 KUB TECHNOLOGIES: COMPANY OVERVIEW 614

TABLE 993 KUB TECHNOLOGIES: PRODUCTS OFFERED 614

11.1.18 MEDIKORS INC. 615

TABLE 994 MEDIKORS INC.: COMPANY OVERVIEW 615

TABLE 995 MEDIKORS INC.: PRODUCTS OFFERED 615

11.1.19 VIEWORKS CO., LTD. 616

TABLE 996 VIEWORKS CO., LTD.: COMPANY OVERVIEW 616

TABLE 997 VIEWORKS CO., LTD.: PRODUCTS OFFERED 616

TABLE 998 VIEWORKS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 617

11.1.20 AI4R 618

TABLE 999 AI4R: COMPANY OVERVIEW 618

TABLE 1000 AI4R: PRODUCTS OFFERED 618

11.2 OTHER PLAYERS 619

11.2.1 ANALYTIK JENA GMBH + CO. KG 619

11.2.2 ITHERA MEDICAL GMBH 619

11.2.3 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. 620

11.2.4 HAWKCELL SAS 60

11.2.5 MILTENYI BIOTEC 621

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX 622

12.1 DISCUSSION GUIDE 622

12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 627

12.3 CUSTOMIZATION OPTIONS 629

12.4 RELATED REPORTS 629

12.5 AUTHOR DETAILS 630

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

シングルユーザ	マルチユーザ	コーポレート	エンタープライズサイト
USD4,950	USD6,650	USD8,150	USD10,000

ライセンスタイプ2

シングルユーザ	マルチユーザ	コーポレート	エンタープライズサイト
USD7,150	USD8,500	USD9,650	USD11,000

ライセンスタイプ3

シングルユーザ	マルチユーザ	コーポレート	エンタープライズサイト
USD8,150	お問合せください	お問合せください	お問合せください

ライセンスタイプ4

シングルユーザ	マルチユーザ	コーポレート	エンタープライズサイト
USD9,000	USD10,500	USD12,000	USD13,500

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

シングルユーザ	コーポレート
USD 2,650	USD 4,250

ご購入に関するご案内

価格・納期について

価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
ライセンス
- シングルユーザライセンス
  - 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
  - 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
  - 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
  - 特別ライセンスです。適用範囲についてはお問合せください。
納品形態
- Eメール
納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

Market Research Future 価格表
シングルユーザライセンス	USD 2,950
エンタープライズライセンス	USD 5,250

Market Research Future 価格表
シングルユーザライセンス	USD 4,950
エンタープライズライセンス	USD 7,250

ライセンス別の価格
シングルユーザライセンス	USD 3,500
2-5ユーザライセンス	USD 4,200
サイトライセンス	USD 5,040
エンタープライズライセンス	USD 6,048

ライセンス別の価格
シングルユーザライセンス	USD 5,500
2-5ユーザライセンス	USD 6,600
サイトライセンス	USD 7,920
エンタープライズライセンス	USD 9,504

ライセンス別の価格
シングルユーザライセンス	USD 1,100
コーポレートライセンス	USD 1,500

前臨床画像市場 : 2029年までの世界予測

Preclinical Imaging Market - Global Forecast To 2029

Table of Contents

ライセンス別価格表

ご購入に関するご案内

価格・納期について

ご注文方法

その他

最新調査レポート

医療・医薬の最新記事8件

手術用ガウンとドレープ市場規模、シェア、動向、2030年までの世界予測

IVD（体外診断）ラボウェア市場規模、シェア、動向、2030年までの世界予測

医療用レンズ市場調査レポート　2025年

バイオチップ市場規模、シェア、動向、2030年までの世界予測

オリゴヌクレオチド複合体：世界市場シェアとランキング、総売上高と需要予測　2025-2031年

血糖値モニター市場規模、シェア、動向、2030年までの世界予測

スマートホームヘルスケアのマーケットデータ　2025年第4四半期

血管イメージング市場規模、シェア、動向、2030年までの世界予測

ライセンス別の価格
シングルユーザライセンス	USD 1,600
コーポレートライセンス	USD 2,200

ライセンス別の価格
シングルユーザライセンス	USD 2,900
コーポレートライセンス	USD 4,500